1. Home
  2. INTT vs CDXS Comparison

INTT vs CDXS Comparison

Compare INTT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

SELL

Current Price

$13.01

Market Cap

148.4M

Sector

Technology

ML Signal

SELL

Logo Codexis Inc.

CDXS

Codexis Inc.

SELL

Current Price

$1.35

Market Cap

154.4M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
INTT
CDXS
Founded
1981
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
148.4M
154.4M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
INTT
CDXS
Price
$13.01
$1.35
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
★ $20.00
$6.14
AVG Volume (30 Days)
114.0K
★ 809.8K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.82
EPS
★ 0.06
N/A
Revenue
$66,801,000.00
★ $138,590,000.00
Revenue This Year
$22.35
$4.97
Revenue Next Year
$7.07
$18.69
P/E Ratio
$217.17
★ N/A
Revenue Growth
★ 66.06
32.30
52 Week Low
$7.07
$0.96
52 Week High
$20.00
$2.98

Technical Indicators

Market Signals
Indicator
INTT
CDXS
Relative Strength Index (RSI) 51.00 45.10
Support Level $12.71 $1.27
Resistance Level $15.25 $1.77
Average True Range (ATR) 0.82 0.07
MACD 0.06 0.01
Stochastic Oscillator 41.92 47.51

Price Performance

Historical Comparison
INTT
CDXS

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: